| Autor: |
Abdel-Aziz M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Abdelhafez Mahmoud M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Daboos M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Abdelmaboud M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Akl M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Mahfouz M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Salama A; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Ashour Y; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Mohamed Y; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Hussien M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Azab A; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt., Magid M; Pediatric Surgery Department, Faculty of Medicine, Al-Azhar University hospitals, Cairo, Egypt. |
| Abstrakt: |
Background: Thoracoscopic sympathetic chain interruption is a definitive and effective therapy for severe primary palmar hyperhidrosis (PPH). Well-known methods include sympathectomy, sympathotomy, and clipping, but the occurrence of compensatory sweating offsets these methods. This study aims to report our experience with thoracoscopic sympathetic chain interruption in a large group of patients of age <18 years with PPH, focusing on surgical outcomes, complication rates, and patient satisfaction. Patients and Methods: This retrospective study included patients who underwent thoracoscopic sympathectomy, sympathotomy, or clipping for severe PPH between April 2008 and March 2023 at the Pediatric Surgery Department, Al-Azhar University Hospitals. Demographic and clinical data, operative steps, postoperative outcomes, complications, and patient satisfaction were reviewed from the patients' medical records. Results: During the 15-year study period, 420 children with PPH underwent bilateral thoracoscopic sympathetic chain interruption by either sympathectomy, sympathotomy, or clipping, with a sex ratio of 60% being females. The mean ages were 12 ± 3.48, 13 ± 2.45, and 13 ± 2.45 years, respectively. Sympathectomy was performed in 190 patients (45.2%), sympathotomy in 170 patients (40.5%), and clipping in 60 patients (14.3%). All patients had completed follow-up, with mean periods of ∼43 ± 5 months, 45 ± 3 months, and 42 ± 6 months, respectively. Complete palmar dryness was achieved in 405 patients (overall 96.4%) (97.8% after sympathectomy, 97.05% after sympathotomy, and 90% after clipping), whereas 2.1%, 2.9%, and 10% of patients experienced symptom recurrence, respectively, denoting significant statistical differences. Overall, 94 patients (22.4%) experienced compensatory sweating. Eventually, 409 patients (97.4%) were satisfied with the outcome, whereas 11 patients (2.6%) reported dissatisfaction, yet no significant differences found. Conclusion: The presented three modalities of thoracoscopic sympathetic chain interruption for PPH in children and adolescents are safe and effective, with overall very high postoperative satisfaction, despite a relatively high rate of compensatory sweating in sympathectomy group. Other major complications in this age population were scanty. |
